- F.Bray, J.Ferlay, I.Soerjomataram, R.L.Siegel, L.A.Torre, A.Jemal, Global cancer statistics 2018, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA, Cancer J Clin, 2018, 68, 394-424. https://doi.org/10.3322/caac.21492
- G.K, Panigrahi, P.P. Praharaj, H. Kittaka, A.R. Mridha, O.M. Black, R. Singh, R. Mercer, A. Van Bokhoven, K.C. Torkko, C. Agarwal, Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Med, 2019, 8, 1110-1123. https://doi.org/10.1002/cam4.1885
- J. Ferlay, M. Ervik, F. Lam, M. Colombet, L. Mery, M. Piñeros, A. Znaor, I. Soerjomataram, F. Bray, Global cancer observatory: cancer today. Lyon, France: international agency for research on cancer, 2018, 1-6.
- E.D. Crawford, Epidemiology of prostate cancer. Urology, 2003, 62, 3-12. https://doi.org/10.1016/j.urology.2003.10.013
- J.M. Chan, P.H. Gann, E.L. Giovannucci, Role of diet in prostate cancer development and progression. J Clin Oncol, 2005, 23, 8152-8160. https://doi.org/10.1200/JCO.2005.03.1492
- E, Giovannucci, E.B. Rimm, G.A. Colditz, M.J. Stampfer, A. Ascherio, C.C. Chute, W.C. Willett, A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst, 1993, 85, 1571-1579. https://doi.org/10.1093/jnci/85.19.1571
- L.N. Kolonel, A.M. Nomura, R.V. Cooney, Dietary fat and prostate cancer: current status. J Natl Cancer Inst, 1999, 91, 414-428. https://doi.org/10.1093/jnci/91.5.414
- M.S. Willis, F.H. Wians Jr, The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta, 2003, 330(1-2), 57-83. https://doi.org/10.1016/S0009-8981(03)00048-2
- N.R. Perdana, C.A. Mochtar, R. Umbas, A.R.A. Hamid, The risk factors of prostate cancer and its prevention: a literature review. Acta Med Indones, 2017, 48, 228-238.
- W. Zhang, X. Zheng, S. Shen, X. Wang, Doxorubicin-loaded magnetic nanoparticle clusters for chemo-photothermal treatment of the prostate cancer cell line PC3. Biochem Biophys Res Commun, 2015, 466, 278-282. https://doi.org/10.1016/j.bbrc.2015.09.036
- S.Y. Madani, N. Naderi, O. Dissanayake, A. Tan, A.M. Seifalian, A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine, 2011, 6, 2963. https://doi.org/10.2147/IJN.S16923
- X. Yao, P. Huang, Z. Nie, Cyclodextrin-based polymer materials: from controlled synthesis to applications, Prog. Polym Sci, 2019, 93, 1-35. https://doi.org/10.1016/j.progpolymsci.2019.03.004
- T.K. Dash, V.B. Konkimalla, Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release, 2012, 158, 15-33. https://doi.org/10.1016/j.jconrel.2011.09.064
- A. Azadi, M. Hamidi, M.R. Rouini, Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: preparation and in vitro/in vivo characterization. Int J Biol Macromol, 2013, 62, 523-530. https://doi.org/10.1016/j.ijbiomac.2013.10.004
- J.H. Lee, K.J. Chen, S.H. Noh, M.A. Garcia, H. Wang, W.Y. Lin, H. Jeong, B.J. Kong, D.B. Stout, J. Cheon, On demand drug release system for in vivo cancer treatment through self‐assembled magnetic nanoparticles. Angew Chem Int Ed, 2013, 125, 4480-4484. https://doi.org/10.1002/ange.201207721
- X. Yang, D. He, X. He, K. Wang, Z. Zou, X. Li, H. Shi, J. Luo, X. Yang, Glutathione Mediated Degradation of Surface‐Capped MnO2 for Drug Release from Mesoporous Silica Nanoparticles to Cancer Cells. Part Part Syst Charact, 2015, 32, 205-212. https://doi.org/10.1002/ppsc.201400092
- D. Ho, J.W. Leong, R.C. Crew, M. Norret, M.J. House, P.J. Mark, B.J. Waddell, K.S. Iyer, J.A. Keelan, Maternal-placental-fetal biodistribution of multimodal polymeric nanoparticles in a pregnant rat model in mid and late gestation. Sci Rep, 2017, 7, 1-11. https://doi.org/10.1038/s41598-017-03128-7
- A. Schroeder, D.A. Heller, M.M. Winslow, J.E. Dahlman, G.W. Pratt, R. Langer, T. Jacks, D.G. Anderson, Treating metastatic cancer with nanotechnology. Nat Rev Cancer 2012, 12, 39-50. https://doi.org/10.1038/nrc3180
- R. Kumar, A. Kulkarni, J. Nabulsi, D.K. Nagesha, R. Cormack, M.G. Makrigiorgos, S. Sridhar, Facile synthesis of PEGylated PLGA nanoparticles encapsulating doxorubicin and its in vitro evaluation as potent drug delivery vehicle. Drug Deliv Transl, 2013, 3, 299-308. https://doi.org/10.1007/s13346-012-0124-9
- A.D. Salaam, P.T. Hwang, A. Poonawalla, H.N. Green, H.w. Jun, D. Dean. Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer. Nanotechnology, 2014, 25, 425103. https://doi.org/10.1088/0957-4484/25/42/425103
- H.J. Kwon, S. Park, Local delivery of antiproliferative agents via stents. Polymers, 2014 6, 755-775. https://doi.org/10.3390/polym6030755
- M. Shaikh, G. Kichenadasse, N.R. Choudhury, R. Butler, S. Garg, Non-vascular drug eluting stents as localized controlled drug delivery platform: preclinical and clinical experience. J Control Release, 2013, 172, 105-117. https://doi.org/10.1016/j.jconrel.2013.08.010
- M. Arafat, P. Fouladian, A. Blencowe, H. Albrecht, Y. Song, S. Garg, Drug-eluting non-vascular stents for localised drug targeting in obstructive gastrointestinal cancers. J Control Release, 2019, 308, 209-231. https://doi.org/10.1016/j.jconrel.2019.07.001
- S. Baudis, F. Nehl, S.C. Ligon, A. Nigisch, H. Bergmeister, D. Bernhard, J. Stampfl, R. Liska, Elastomeric degradable biomaterials by photopolymerization-based CAD-CAM for vascular tissue engineering. Biomed Mater, 2011, 6, 055003. https://doi.org/10.1088/1748-6041/6/5/055003
- J.Y. Cherng, T.Y. Hou, M.F. Shih, H. Talsma, W.E. Hennink. Polyurethane-based drug delivery systems. Int J Pharm, 2013, 450, 145-162. https://doi.org/10.1016/j.ijpharm.2013.04.063
- C. Akduman, I. Özgüney, E.P.A. Kumbasar, Preparation and characterization of naproxen-loaded electrospun thermoplastic polyurethane nanofibers as a drug delivery system. Mater Sci Eng C, 2016, 64, 383-390. https://doi.org/10.1016/j.msec.2016.04.005
- M.B. Lowinger, S.E. Barrett, F. Zhang, R.O. Williams, Sustained release drug delivery applications of polyurethanes. Pharmaceutics, 2018, 10, 55. https://doi.org/10.3390/pharmaceutics10020055
- K.M. Gupta, S.M. Pearce, A.E. Poursaid, H.A. Aliyar, P.A. Tresco, M.A. Mitchnik, P.F. Kiser, Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. J Pharm Sci, 2008, 97, 4228-4239. https://doi.org/10.1002/jps.21331
- L.P. Bucky, H.P. Ehrlich, S. Sohoni, Jr. J.W. May, The capsule quality of saline-filled smooth silicone, textured silicone, and polyurethane implants in rabbits: a long-term study. Plast Reconstr Surg, 1994, 93,1123-1131; discussion 1132. https://doi.org/10.1097/00006534-199405000-00002
- S. Sommer, A. Ekin, D.C. Webster, S.J Stafslien, J. Daniels, L.J. VanderWal, S.E. Thompson, M.E. Callow, J.A. Callow, A preliminary study on the properties and fouling-release performance of siloxane-polyurethane coatings prepared from poly (dimethylsiloxane)(PDMS) macromers. Biofouling, 2010, 26,961-972. https://doi.org/10.1080/08927014.2010.531272
- T.K. Dash, V.B. Konkimalla, Polymeric modification and its implication in drug delivery: poly-ε-caprolactone (PCL) as a model polymer. Mol Pharm, 2012, 9, 2365-2379. https://doi.org/10.1021/mp3001952
- A. Shababdoust , M. Zandi, M. Ehsani, P. Shokrollahi, R. Foudazi, Controlled curcumin release from nanofibers based on amphiphilic-block segmented polyurethanes. Int J Pharm, 2020, 575, 118947. https://doi.org/10.1016/j.ijpharm.2019.118947
- S. Gao, A. Zhou, B. Cao, J. Wang, F. Li, G. Tang, Z. Jiang, A. Yang, R. Xiong, J. Lei, A tunable temperature-responsive and tough platform for controlled drug delivery, 2021, New J Chem. https://doi.org/10.1039/D1NJ01356D
- M. Irani, G.M.M. Sadeghi, I. Haririan, A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Int J Biol, 2017, 97, 744-751. https://doi.org/10.1016/j.ijbiomac.2017.01.073
- M. Shahzamani, N.G. Ebrahimi, Effect of Solvent on the Properties of TPU (PCL)/PCL Blends Prepared by Solution Method.
- C.P. Teng, K.Y. Mya, K.Y. Win, C.C. Yeo, M. Low, C. He, M.Y. Han, Star-shaped polyhedral oligomeric silsesquioxane-polycaprolactone-polyurethane as biomaterials for tissue engineering application. NPG Asia Mater, 2014, 6, e142-e142. https://doi.org/10.1038/am.2014.102
- S. De Koker, R. Hoogenboom, B.G. De Geest, Polymeric multilayer capsules for drug delivery. Chem Soc Rev, 2012, 41, 2867-2884. https://doi.org/10.1039/c2cs15296g
- T.L. Doane, C. Burda. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev. 2012, 41, 2885-2911. https://doi.org/10.1039/c2cs15260f
- C.F. Thorn, C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T.E. Klein, R.B. Altman, Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics, 2011, 21, 440. https://doi.org/10.1097/FPC.0b013e32833ffb56
- X. Xu, X. Chen, X. Wang, X. Jing, The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning. Eur. J. Pharm. Biopharm, 2008, 70(1), 165-170. https://doi.org/10.1016/j.ejpb.2008.03.010
- F. Yang, J. Xu, M. Fu, J. Ji, L. Chi, G. Zhai, Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin. J. Drug Target, 2020, 28(10), 993-1011. https://doi.org/10.1080/1061186X.2020.1766474
- S .Davaran, et al, Physicochemical characteristics of Fe 3 O 4 magnetic nanocomposites based on poly (N-isopropylacrylamide) for anti-cancer drug delivery. Asian Pacific Journal of Cancer Prevention, 2014. 15(1), p. 49-54. https://doi.org/10.7314/APJCP.2014.15.1.49
- C. Dhand, N. Dwivedi, H. Sriram, S. Bairagi, D. Rana, R. Lakshminarayanan, M. Ramalingam, S. Ramakrishna, Nanofiber composites in drug delivery. In: Nanofiber Composites for Biomedical Applications. Elsevier, 2017, 199-223. https://doi.org/10.1016/B978-0-08-100173-8.00008-9
- B. Dhandayuthapani, D. Sakthi kumar. Biomaterials for biomedical applications. Biomedical Applications of Polymeric Materials and Composites, 2016, 1-20. https://doi.org/10.1002/9783527690916.ch1
- P.X. Ma, J.W. Choi, Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng, 2001, 7, 23-33. https://doi.org/10.1089/107632701300003269
- S. Zhang, Z.T. Li, M. Liu, J.R. Wang, M.Q. Xu, Z.Y. Li, X.C. Duan, Y.L. Hao, X.C. Zheng, H. Li, Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells. J Control Release, 2019, 295, 102-117. https://doi.org/10.1016/j.jconrel.2018.12.034
- W. Zheng, M. Li, Y. Lin, X. Zhan, Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer. Biomed Pharmacother, 2018, 108,565-573. https://doi.org/10.1016/j.biopha.2018.09.039
- M. Norouzi, V. Yathindranath, J.A. Thliveris, B.M. Kopec, T.J. Siahaan, D.W. Miller, Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: A combinational approach for enhanced delivery of nanoparticles. Sci Rep, 2020, 10, 1-18. https://doi.org/10.1038/s41598-020-68017-y
- E. Tsakalozou, A.M. Eckman, Y. Bae, Combination effects of docetaxel and doxorubicin in hormone-refractory prostate cancer cells, 2012, Biochem Res Int 2012. https://doi.org/10.1155/2012/832059
- R.Mohammadi Abandansari, H. Parsian, F. Kazerouni, R. Porbagher, E Zabihi, A. Rahimipour, Effect of simultaneous treatment with royal jelly and doxorubicin on the survival of the prostate cancer cell line (pc3), an in vitro study, 2018, Int J Cancer Manag 11. https://doi.org/10.5812/ijcm.13780
- F. Almutairi, T.C. Peterson, M. Molinari, M.J. Walsh, I. Alwayn, K.M. Peltekian, Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver Transplant, 2009, 15, 504-508. https://doi.org/10.1002/lt.21710
- L. Zhuang, J. Kim, R.M. Adam, K.R. Solomon, M.R. Freeman, Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Investig, 2005, 115, 959-968.
- K.R. Solomon, K. Pelton, K. Boucher, J. Joo, C. Tully, D. Zurakowski, C.P. Schaffner, J. Kim, M.R. Freeman, Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol, 2009, 174, 1017-1026. https://doi.org/10.2353/ajpath.2009.080551
54. C. Pisani, M. Ramella, R. Boldorini, G. Loi, M. Billia, F. Boccafoschi, A. Volpe, M. Krengli, Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose, Scientific reports, 10 (2020) 7050. https://doi.org/10.1038/s41598-020-64062-9
55. R. Habibey, M. Ajami, S.A. Ebrahimi, A. Hesami, S. Babakoohi, H. Pazoki-Toroudi, Nitric oxide and renal protection in morphine-dependent rats, Free Radical Biology and Medicine, 49 (2010) 1109-1118. https://doi.org/10.1016/j.freeradbiomed.2010.06.024
56. M. Ajami, S. Eghtesadi, J.M. Razaz, N. Kalantari, R. Habibey, M.A. Nilforoushzadeh, M. Zarrindast, H. Pazoki-Toroudi, Expression of Bcl-2 and Bax after hippocampal ischemia in DHA+ EPA treated rats, Neurological Sciences, 32 (2011) 811-818. https://doi.org/10.1007/s10072-011-0621-5
57. G. Javedan, F. Shidfar, S.H. Davoodi, M. Ajami, F. Gorjipour, A. Sureda, S.M. Nabavi, M. Daglia, H. Pazoki‐Toroudi, Conjugated linoleic acid rat pretreatment reduces renal damage in ischemia/reperfusion injury: Unraveling antiapoptotic mechanisms and regulation of phosphorylated mammalian target of rapamycin, Molecular nutrition & food research, 60 (2016) 2665-2677. https://doi.org/10.1002/mnfr.201600112
58. H. Ghaznavi, S. Mehrzadi, B. Dormanesh, S.M.T.H. Tabatabaei, H. Vahedi, A. Hosseinzadeh, H. Pazoki-Toroudi, A. Rashidian, Comparison of the protective effects of melatonin and silymarin against gentamicin-induced nephrotoxicity in rats, Journal of evidence-based complementary & alternative medicine, 21 (2016) NP49-NP55. https://doi.org/10.1177/2156587215621672
59. F.Z. Mehrjerdi, N. Aboutaleb, H. Pazoki-Toroudi, M. Soleimani, M. Ajami, M. Khaksari, F. Safari, R. Habibey, The protective effect of remote renal preconditioning against hippocampal ischemia reperfusion injury: role of KATP channels, Journal of molecular neuroscience, 57 (2015) 554-560. https://doi.org/10.1007/s12031-015-0636-0